April 21, 2025 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (Nasdaq: DSGN), a clinical-stage biotechnology company developing treatments ... that causes corneal endothelial cell dysfunction ...

how nerves recover after an injury and could contribute to understanding what happens in rare diseases that affect corneal ...

Traditional corneal transplants, the standard treatment for vision rehabilitation, do not work in LSCD patients because the ...